Login to Your Account



EMA launches Prime to accelerate, improve regulatory process

By Nuala Moran
Staff Writer

Monday, March 7, 2016

LONDON – The EMA has launched its latest scheme for accelerating the assessment of drugs, promising support tailored to the stage of development, ongoing access to its approvals committee and more help with plotting a route through to approval.

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription